NEW YORK (Reuters Health) – Coronary heart disease that continues to progress to serious events in patients whose LDL levels have been brought down adequately — called “residual…
NEW YORK (Reuters Health) – Recommendations issued by the European Society of Cardiology emphasize the need to consider the clinical context in interpreting cardiac troponin readings in acute…
NEW YORK (Reuters Health) – Very elderly patients with ST-segment elevation MI can do quite well with successful primary percutaneous intervention, as long they aren’t in cardiogenic shock…
NEW YORK (Reuters Health) – Patients with ST-elevation myocardial infarction (STEMI) who receive timely guideline-based reperfusion therapy — fibrinolysis within 30 minutes of arrival and primary percutaneous coronary…
NEW YORK (Reuters Health) – In patients with ST-segment elevation myocardial infarction (STEMI), most of the benefits of sirolimus-eluting stents over bare-metal stents accrue during the first year…
NEW YORK (Reuters Health) – Compared to a modified Blalock-Taussig (MBT) shunt, a right ventricle-pulmonary artery (RV-PA) shunt achieves higher 12-month transplant-free survival in babies with hypoplastic left…
NEW YORK (Reuters Health) – Superficial, or “nuisance,” bleeding troubled more than a quarter of patients on dual-antiplatelet therapy following the implantation of drug-eluting stents, according to new…
NEW YORK (Reuters Health) – Long-term follow-up of more than 2000 patients with unprotected left main coronary artery disease shows stenting to be as effective as coronary artery…
NEW YORK (Reuters Health) – Coronary artery stenting does not reduce long-term rates of myocardial infarction (MI) or mortality in patients with stress-positive stable coronary artery disease, German…
NEW YORK (Reuters Health) – Clopidogrel reloading does not benefit patients undergoing percutaneous coronary intervention (PCI) who are already on chronic clopidogrel therapy, Italian researchers reported online April…